Resultats globals: 1 registres trobats en 0.02 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
11 p, 797.9 KB Strategies for Continued Successful Treatment in Patients with Alzheimer's Disease : An Overview of Switching Between Pharmacological Agents / Blesa, Rafael (Institut d'Investigació Biomèdica Sant Pau) ; Toriyama, Kazuhiro (Novartis Pharma KK, Tokyo) ; Ueda, Kengo (Novartis Pharma KK, Tokyo) ; Knox, Sean (Novartis Pharma AG, Basel) ; Grossberg, George (Saint Louis University School of Medicine) ; Universitat Autònoma de Barcelona
Alzheimer's disease (AD) is the most common cause of dementia, characterized by a progressive decline in cognition and function. Current treatment options for AD include the cholines-terase inhibitors (ChEIs) donepezil, galantamine, and rivastigmine, as well as the N-methyl-D-aspartate receptor antagonist memantine. [...]
2018 - 10.2174/1567205015666180613112040
Current Alzheimer Research, Vol. 15 (october 2018) , p. 964-974  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.